The Central Drugs Standard Control Organization (CDSCO) under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, is the National Regulatory Authority for drugs and cosmetics. CDSCO ensures the safety, efficacy, and quality of medical products in India by regulating drugs, conducting clinical trials, and controlling the quality of imported drugs. It also collaborates with state regulators for the licensing of critical drugs like blood products, IV fluids, vaccines, and sera.
We're tracking Central Drugs Testing Laboratory's market expansion
How Central Drugs Testing Laboratory's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
Central Drugs Testing LaboratoryYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
CDSCO proposes Braille labels and QR codes on medicine packs to aid visually impaired. Minimum font size of 9 suggested for labels.
CDSCO cancels registration of QR 678-Neo, an anti-hair loss product, for making unapproved medical claims.
CDSCO seeks stricter enforcement after banned antibiotics were found responsible for 43% of shrimp export rejections, highlighting compliance issues in India's seafood industry.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Central Drugs Testing Laboratory's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
